News
CCM
1.990
+7.57%
0.140
Concord Medical Announces Its Subsidiary's Application Filing For Potential Listing On The Stock Exchange Of Hong Kong Limited
Concord Medical Announces Its Subsidiary's Application Filing for Potential Listing on The Stock Exchange of Hong Kong Limited BEIJING, June 1, 2022 /PRNewswire/ -- Concord Medical Services Holdings
Benzinga · 06/01 20:20
Concord Medical Announces Its Subsidiary's Application Filing for Potential Listing on The Stock Exchange of Hong Kong Limited
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an exten...
PR Newswire · 06/01 20:15
Concord Medical Services Holdings (NYSE:CCM) adds CN¥10.0m to market cap in the past 7 days, though investors from five years ago are still down 62%
This week we saw the Concord Medical Services Holdings Limited ( NYSE:CCM ) share price climb by 17%. But that is...
Simply Wall St. · 05/12 11:47
Concord Medical Files 2021 Annual Report on Form 20-F
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers, premium cancer hospitals, and specialty ca...
PR Newswire · 04/29 23:15
SND, VLD and ADN among mid-day movers
Gainers: Advent Technologies (ADN) +79%. Tufin Software Technologies (TUFN) +43%. Mobiquity Technologies (OTCQB:MOBQ) +30%. Missfresh (MF) +25%. Venator Materials (VNTR) +17%. Team (TISI) +16%. Concord Medical Services (CCM) +15%. NextDecade (NEXT) +15%. S...
Seekingalpha · 04/06 16:52
50 Biggest Movers From Friday
 
Benzinga · 02/07 09:21
Concord Medical reports 1H results
Concord Medical (NYSE:CCM): 1H Non-GAAP EPADS of -$0.38; GAAP EPADS of -$0.39. Revenue of $29.9M (+132.4% Y/Y) Press Release Adjusted EBITDA was -$19.8M in the first half of 2021, compared to
Seekingalpha · 12/10/2021 10:49
Concord Medical Reports Financial Results for the First Half of 2021
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research, and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalo...
PR Newswire · 12/10/2021 10:30
Concord Medical Schedules 2020 Annual Meeting of Shareholders
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalon...
PR Newswire · 11/29/2021 11:25
Guangzhou Concord Cancer Center Becomes a Designated Hospital of Social Healthcare Insurance
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalon...
PR Newswire · 10/21/2021 08:00
Is Concord Medical Services Holdings Limited (NYSE:CCM) Popular Amongst Insiders?
A look at the shareholders of Concord Medical Services Holdings Limited ( NYSE:CCM ) can tell us which group is most...
Simply Wall St. · 10/18/2021 11:25
Top Premarket Decliners
MT Newswires · 09/28/2021 08:27
BRIEF-Concord Medical Purchases Additional Proton Therapy System For It's Shanghai Concord Cancer Center
reuters.com · 09/10/2021 11:06
Kadmon, ICU Medical leads healthcare gainers; INmune Bio, Inozyme Pharma among major losers
Gainers: Kadmon (NASDAQ:KDMN) +73%, ICU Medical (NASDAQ:ICUI) +32%, Candel Therapeutics (NASDAQ:CADL) +17%, Gain Therapeutics (NASDAQ:GANX) +9%, Concord Medical Services (NYSE:CCM) +9%. Losers: INmune Bio (NASDAQ:INMB) -22%, Inozyme Pharma (NASDAQ:INZY) -1...
Seekingalpha · 09/08/2021 14:58
Concord Medical Completes RMB 400 Million Funding Round Led by Consortium Investors
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializes in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operati...
PR Newswire · 08/23/2021 10:10
Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalon...
PR Newswire · 06/11/2021 10:11
Concord Medical Services' Specialty Cancer Hospital in China Commences Operations
MT Newswires · 06/11/2021 06:38
75 Biggest Movers From Yesterday
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail investor interest in the stock.
Benzinga · 06/09/2021 09:01
Concord Medical receives deficiency notice from NYSE over delayed filing
Concord Medical (CCM) has received notice from NYSE that the delay in filing its annual report on Form 20-F for the fiscal year ended December 31, 2020 does not meet its listing requirement
Seekingalpha · 05/25/2021 10:22
Concord Medical Services Gets Non-Compliance Notification From NYSE
MT Newswires · 05/25/2021 06:31
More
Webull provides a variety of real-time CCM stock news. You can receive the latest news about Concord Medical through multiple platforms. This information may help you make smarter investment decisions.
About CCM
Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company's segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China. Its network consists of approximately 130 cooperative centers based in over 70 hospitals, spanning approximately 60 cities across 25 provinces and administrative regions in China. Its network includes approximately 60 radiotherapy centers and over 60 diagnostic imaging centers and approximately seven centers. The Company's cooperative centers are equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner or magnetic resonance imaging (MRI) scanner.